BackLB PharmaceuticalsCommon Stock Overview

LB PharmaceuticalsCommon Stock Total Liabilities

Latest total liabilities for LBRX: $15M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$14.79M

Peer average

Loading

LB PharmaceuticalsCommon Stock Total Liabilities History

Loading

LB PharmaceuticalsCommon Stock vs. peers: Total Liabilities Comparison

Loading

LB PharmaceuticalsCommon Stock Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

LB PharmaceuticalsCommon Stock (LBRX) FAQ

The latest total liabilities for LBRX is $15M as of March 2026. Investors often review this figure alongside LB PharmaceuticalsCommon Stock's historical trend and sector peers before judging valuation or financial health.

A total liabilities figure of $15M for LBRX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting LBRX's total liabilities ($15M), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack LB PharmaceuticalsCommon Stock's total liabilities against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.